Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Gene therapy for choroideremia enters clinic

June 8, 2012

First-in-patient trial evaluates GSK-2256098

June 7, 2012

First-in-human trial of LY-2228820 completed

June 7, 2012

Phase I trial assesses volasertib combination regimens for solid tumors

June 7, 2012

Phase II results reported on amatuximab

June 7, 2012

SDF-1 inhibition may limit transplant vasculopathy

June 6, 2012

Phase I study evaluates peptide vaccine including cancer/testis antigens

June 6, 2012

Clinical studies assess daily and twice-daily dosing of golvatinib

June 6, 2012

CalciMedica describes new class of immunomodulators

June 6, 2012

OMP-59R5 well tolerated in phase I study

June 6, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...